World Osteoporosis Day highlights the silent threat of bone loss in India, urging prevention and treatment for stronger bones ...

Nearly a decade ago, Kristen Beavers, who studies safe ways for older adults to lose weight, began asking whether weighted ...

Romosozumab shows bone mineral density gain in postmenopausal women with severe osteoporosis, irrespective of prior exposure ...

The new approvals bring the number of denosumab biosimilars in the US to eight, but price reductions are not yet substantial.

Following an infusion of zoledronate acid in low-risk postmenopausal women, fracture risk reduction emerged only 5-10 years ...

These include the RANKL inhibitor denosumab (Prolia), the anabolic agents teriparatide (Forteo) and abaloparatide (Tymlos), ...

"Entera’s oral osteoporosis drug meets endpoints in Phase II trial" was originally created and published by Clinical Trials ...

As such, at ESMO 2025, the investigators analyzed patients with or without baseline bone metastases treated with lenvatinib + pembrolizumab versus sunitinib in the CLEAR study with ∼4 years follow-up ...

What is the ‘golden dose’ and what are the risks? Medical News Today asks four experts to weigh in on the trend of trying to get a fifth dose out of Mounjaro.

During a live event, Lori Wirth, MD, discussed next steps for treating a patient with progressive, radioactive ...

The ag industry is witnessing the evolution of glufosinate herbicides with the introduction of L-glufosinate products. Learn ...

Diabetes significantly impacts bone health, often overlooked. Both Type 1 and Type 2 diabetes can lead to weakened bones, ...